Metronidazole Noridem

Metronidazole, the active ingredient in Metronidazole Noridem, is a nitroimidazole presented as an intravenous solution for intravenous use. It treats anaerobic bacterial infections, certain protozoal diseases and related conditions in adult patients. GNH USA supplies Metronidazole Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Metronidazole is an antibiotic that targets anaerobic bacteria and certain protozoa.

- Anaerobic bacterial infections: effective in treating infections caused by anaerobic organisms. - Bacterial vaginosis: restores normal vaginal flora by eliminating pathogenic anaerobes. - Trichomoniasis: eradicates Trichomonas vaginalis infection. - Amebic liver abscess: eliminates Entamoeba histolytica in hepatic lesions. - Clostridioides difficile infection: reduces toxin‑producing C. difficile in the colon.

Metronidazole may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Metallic taste: transient alteration of taste perception. - Headache: occasional mild headache. - Diarrhoea: loose stools during therapy.

Serious or Rare Side Effects: - Seizures: rare neurologic events requiring immediate attention. - Peripheral neuropathy: tingling or numbness in extremities. - Severe allergic reactions: anaphylaxis or angioedema requiring emergency care.

Metronidazole requires careful use in specific patient groups.

- Renal impairment: assess kidney function and adjust therapy as needed. - Hepatic dysfunction: monitor liver enzymes during treatment. - Alcohol consumption: avoid alcohol to prevent disulfiram‑like reactions. - Pregnancy: prescribe only when benefits outweigh potential risks. - Duplicate therapy: avoid concomitant use of another metronidazole product. - Store at ambient temperature: keep in original container, protect from light and moisture.

Metronidazole can interact with several medicines.

Major Interactions (Avoid): - Alcohol: may cause severe flushing, tachycardia, and hypotension. - Warfarin: can increase anticoagulant effect and bleeding risk. - Lithium: may raise lithium serum concentrations leading to toxicity.

Moderate Interactions (Monitor Closely): - Cimetidine: may elevate metronidazole plasma levels. - Phenobarbital: may reduce metronidazole efficacy. - Oral contraceptives: may diminish hormonal contraceptive effectiveness.